drug delivery

Development of a Chewable Tablet From Dugdh?Malaky?Di Yoga: An Ayurvedic Preparation.

Development of a chewable tablet from Dugdh?malaky?di Yoga: An Ayurvedic preparation.

Anc Sci Life. 2012 Jul; 32(1): 34-7
Santhosh SB, Ambi AB, Hiremath RR, Mannur VS

?malaki (Embelica officinalis Gaertn.) is one of the most celebrated herbs in the… Continue reading →

How to Optimize Binding of Coated Nanoparticles: Coupling of Physical Interactions, Molecular Organization and Chemical State.

How to Optimize Binding of Coated Nanoparticles: Coupling of Physical Interactions, Molecular Organization and Chemical State.

Biomater Sci. 2013 Aug 1; 1(8): 814-823
Nap RJ, Szleifer I

One of the key challenges in the development of nano carriers for… Continue reading →

Advanced Drug Delivery to the Lymphatic System: Lipid-Based Nanoformulations.

Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.

Int J Nanomedicine. 2013; 8: 2733-44
Khan AA, Mudassir J, Mohtar N, Darwis Y

The delivery of drugs and bioactive compounds via the lymphatic system is complex and dependent on… Continue reading →

A Report From the American Society of Hypertension 28th Annual Scientific Meeting and Exposition (May 15-18, 2013 – San Francisco, California, U.S.A.).

A report from the American Society of Hypertension 28th Annual Scientific Meeting and Exposition (May 15-18, 2013 – San Francisco, California, U.S.A.).

Drugs Today (Barc). 2013 Jul; 49(7): 463-70
Rabasseda X

A wide selection of antihypertensive drugs are currently… Continue reading →

An Engineering Approach to Biomedical Sciences: Advanced Strategies in Drug Delivery Systems Production.

An engineering approach to biomedical sciences: advanced strategies in drug delivery systems production.

Transl Med UniSa. 2012 Sep; 4: 3-11
Barba AA, Dalmoro A, d’Amore M

Development and optimization of novel production techniques for drug delivery systems are fundamental… Continue reading →

Gabapentin Add-on for Drug-Resistant Partial Epilepsy.

Gabapentin add-on for drug-resistant partial epilepsy.

Cochrane Database Syst Rev. 2013 Jul 25; 7: CD001415
Al-Bachari S, Pulman J, Hutton JL, Marson AG

The majority of people with epilepsy have a good prognosis and their seizures are well controlled… Continue reading →

Current and Emerging Treatments for Absence Seizures in Young Patients.

Current and emerging treatments for absence seizures in young patients.

Neuropsychiatr Dis Treat. 2013; 9: 963-75
Vrielynck P

In this report, we review the pharmacological and non-pharmacological treatments of the different absence seizure types as recently recognized by the… Continue reading →

Cost-Effectiveness of Zofenopril in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: A Post Hoc Analysis of SMILE-4.

Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4.

Clinicoecon Outcomes Res. 2013; 5: 317-25
Borghi C, Ambrosioni E, Omboni S, Cicero AF, Bacchelli S, Esposti DD, Novo… Continue reading →

Is Sulphadoxine-Pyrimethamine (SP) Still Useful as the First-Line Antimalarial Drug in Malawi or It Must Be Quickly Withdrawn From the Antimalarial Repertoire?

Is sulphadoxine-pyrimethamine (SP) still useful as the first-line antimalarial drug in Malawi or it must be quickly withdrawn from the antimalarial repertoire?

Malawi Med J. 2007 Mar; 19(1): 37-8
Nkhoma S

HubMed – drug

Application of design of experiment… Continue reading →

Hepatoprotective and Antioxidant Effects of Saponarin, Isolated From Gypsophila Trichotoma Wend. on Paracetamol-Induced Liver Damage in Rats.

Hepatoprotective and Antioxidant Effects of Saponarin, Isolated from Gypsophila trichotoma Wend. on Paracetamol-Induced Liver Damage in Rats.

Biomed Res Int. 2013; 2013: 757126
Simeonova R, Vitcheva V, Kondeva-Burdina M, Krasteva I, Manov V, Mitcheva M

The hepatoprotective potential of… Continue reading →